China Bismuth Subsalicylate market went up in the first half of November, following the upward trend in October as production improved and pharmaceutical demand was firm. Chinese refining plants ran at higher rates after the earlier supply disruptions and inventory at major distribution centers was tight, so suppliers were confident to keep firmer prices. October’s increase laid the foundation for the continuation of the strength, with steady export to Asia, Europe and Americas kept the market sentiment stable. Although raw bismuth price went down a bit, refined Bismuth Subsalicylate was still tight enough to support the upward trend. Logistics was smooth and international inquiry was steady, so exporter was in good position. Demand was strong, driven by active procurement from gastrointestinal drug formulators across the globe and seasonal healthcare demand. Restocking was picking up as buyers were buying ahead of winter cycle. According to market sources, the post-monsoon buying trend and firm FOB offers will keep the prices going up.
